About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in Houston | 78 Studies

Clinical Trials MigraineHouston

Migraine Clinical Trials in Houston

Find 78 clinical trials for migraine near Houston, Texas. Connect with research centers in your area.

All Migraine trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 78 trials

CompletedSafety and Efficacy Study in Adult Subjects With Acute MigrainesThe purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute MigrainesNCT03235479·Birmingham, Alabama and 49 others

Migraine Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedOpen Label Safety Study in Acute Treatment of MigraineThe purpose of this study is to evaluate safety and tolerability of BHV-3000 (rimegepant).NCT03266588·Birmingham, Alabama and 97 others

CompletedA Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of MigraineThe purpose of this study is to evaluate the efficacy and safety of eptinezumab administered intravenously in participants experiencing an acute attack of migraine.NCT04152083·Birmingham, Alabama and 56 others

CompletedEfficacy and Safety Study of E2007 in Migraine ProphylaxisThis was a 22-week, prospective, randomized, double-blind, placebo-controlled, multicenter, parallel-group study that included a 4-week Baseline Phase at the beginning and a…NCT00154063·Oceanside, California and 8 others

CompletedStudy to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine PreventionA study to evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days in participants with episodic migraine.NCT01952574·Phoenix, Arizona and 65 others

RecruitingA Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineThis is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of…NCT07645924·Birmingham, Alabama and 112 others

Active not recruitingA Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in AdultsThe purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing episodic migraine.NCT06047457·Birmingham, Alabama and 104 others

CompletedEffectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual MigraineFemales 18 years of age or older with at least one year history of menstrual migraine (MM) headaches participated in a Phase 4 clinical trial to evaluate the efficacy of…NCT00904098·Stratford, Connecticut and 20 others

CompletedStaccato Prochlorperazine in Migraine (Out Patient)Staccato Prochlorperazine is being developed to treat patients suffering from acute migraine headaches.NCT00422812·Scottsdale, Arizona and 24 others

CompletedStudy to Determine Safety and Efficacy of B244 in Subjects With Episodic MigraineThis is a prospective, randomized, vehicle-controlled, double-blind, multi-center study assessing the safety, tolerability, and efficacy of B244 delivered as an intranasal spray…NCT03488563·Little Rock, Arkansas and 21 others

CompletedA Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)This is a randomized, double-blind, placebo-controlled, crossover, two-attack, out-patient, early-intervention evaluation of subjects who have migraine with or without aura and…NCT00383162·Fresno, California and 25 others

CompletedThe Efficacy and Tolerability of NP101 Patch in the Treatment of Acute MigraineThis study was a randomized, parallel group, double-blind, placebo controlled design to compare the efficacy and tolerability of NP101 to a placebo iontophoretic transdermal patch.NCT00724815·Phoenix, Arizona and 33 others

RecruitingA Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 YearsMigraine is a disease that most often causes moderate to severe headache on one side of the head.NCT06810505·Huntsville, Alabama and 64 others

CompletedTreximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine AttacksThe purpose of this study is to determine the consistency of response for Treximet (sumatriptan/naproxen sodium), formerly known as Trexima, when treating four acute migraine…NCT00240630·Chandler, Arizona and 49 others

CompletedA 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine HeadachesThe purpose of this study is to evaluate the long-term safety of almotriptan malate (a migraine headache medication) in the treatment of migraine headaches in adolescents for up…NCT00257010·Mobile, Alabama and 48 others

RecruitingStudy to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to…NCT05125302·Huntsville, Alabama and 128 others

RecruitingRandomized Study in Children and Adolescents With Migraine: Acute TreatmentThe purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.NCT04649242·Birmingham, Alabama and 245 others

CompletedTREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)This study was designed to determine the efficacy and tolerability of TREXIMET (formerly known as TREXIMA) compared to placebo for the acute treatment of probable migraine, a…NCT00387881·Phoenix, Arizona and 69 others

CompletedStudy to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic MigraineThis study will evaluate safety and tolerability of treatment with atogepant for the prevention of episodic migraine over the course of one year.NCT03700320·Birmingham, Alabama and 111 others

Completed12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic MigraineTo evaluate the safety and tolerability of atogepant 30 mg and 60 mg once a day for the prevention of migraine in participants with episodic migraine.NCT03777059·Chandler, Arizona and 137 others

PreviousPage 3 of 4Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia